Cara Therapeutics(CARA) - 2023 Q4 - Annual Results

Cara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results –Extended cash runway into 2026 with clinical prioritization strategy and reduction in force– STAMFORD, Conn., March 4, 2024 – Cara Therapeutics, Inc. (Nasdaq: CARA), a development-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced financial results and operational highlights for the fourth quarter and full year ended December 31, 2023. 2023 ...